Drugs / activated prothrombin complex concentrate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00221195 | Jun 2003 → Dec 2009 | hemophilia A | Tulane University School of Medicine | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | activated prothrombin complex concentrate | “Drug: activated prothrombin complex concentrate (FEIBA)” NCT00221195 ↗ |
| Known as | FEIBA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00221195 ↗ |